327,538 Shares in Avantor, Inc. (NYSE:AVTR) Acquired by New York State Teachers Retirement System

New York State Teachers Retirement System bought a new position in shares of Avantor, Inc. (NYSE:AVTR) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 327,538 shares of the company’s stock, valued at approximately $8,473,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Jennison Associates LLC lifted its position in shares of Avantor by 113.0% during the 1st quarter. Jennison Associates LLC now owns 2,497,349 shares of the company’s stock worth $63,857,000 after buying an additional 1,325,026 shares during the period. Swedbank AB acquired a new stake in Avantor during the 1st quarter valued at $2,707,000. BNP Paribas Financial Markets increased its holdings in Avantor by 42.4% during the 1st quarter. BNP Paribas Financial Markets now owns 309,394 shares of the company’s stock valued at $7,911,000 after purchasing an additional 92,098 shares in the last quarter. William Blair Investment Management LLC increased its holdings in Avantor by 44.6% during the 1st quarter. William Blair Investment Management LLC now owns 1,047,732 shares of the company’s stock valued at $26,791,000 after purchasing an additional 322,985 shares in the last quarter. Finally, Sound Shore Management Inc. CT acquired a new stake in Avantor during the 2nd quarter valued at $76,412,000. Institutional investors own 95.08% of the company’s stock.

Analyst Ratings Changes

AVTR has been the subject of a number of recent analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and set a $34.00 price target on shares of Avantor in a report on Thursday, September 26th. Morgan Stanley lifted their target price on Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. TD Cowen lifted their target price on Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Citigroup cut Avantor from a “buy” rating to a “neutral” rating and lowered their target price for the company from $30.00 to $23.00 in a research note on Wednesday, July 10th. Finally, Stifel Nicolaus lifted their target price on Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, Avantor has an average rating of “Moderate Buy” and an average target price of $27.57.

Avantor Stock Performance

Shares of NYSE AVTR opened at $22.31 on Monday. The stock has a 50 day moving average price of $25.20 and a 200 day moving average price of $24.17. Avantor, Inc. has a 52 week low of $17.46 and a 52 week high of $28.00. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.05 and a current ratio of 1.54. The stock has a market capitalization of $15.18 billion, a PE ratio of 48.50, a price-to-earnings-growth ratio of 2.70 and a beta of 1.35.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the sale, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.50% of the company’s stock.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.